Abstract
A series of urea and thiourea analogues of fluoxetine (5–17) were synthesized and evaluated for their anorexigenic and antidepressant activities. The related conformationally restrained analogues (20–23) were also prepared for structure–activity relationship (SAR) studies. Many of these derivatives (5, 6, 8, 10, 12, 13, 16, and 23) exhibited significant anorexigenic activity and interestingly were devoid of antidepressant activity, thus emerging as a promising tool for further research work.
Similar content being viewed by others
References
Ankersen M, Dorwald F, Stidsen C, Crider A (1998) Constrained somatostatin agonists and antagonists. WO9818786
Benfield P, Heel RC, Lewis SP (1986) Fluoxetine-a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 32:481–508
Bhandari K, Srivastava S, Shankar G (2004) Synthesis of tetrahydronaphthyl thioureas as potent appetite suppressants. Bioorg Med Chem 12:4189–4196
Bhandari K, Srivastava S, Shankar G, Nath C (2005) Substituted propanolamines and alkylamines derived from fluoxetine as potent appetite suppressants. Bioorg Med Chem 13:1739–1747
Bhandari K, Srivastava S, Shankar G, Nath C (2006) Synthesis and appetite suppressant activity of 1-aryloxy-2-substituted aminomethyltetrahydronaphthalenes as conformationally rigid analogues of fluoxetine. Bioorg Med Chem 14:2535–2544
Blundell JE (1984) Serotonin and appetite. Neuropharmacology 23:1537–51
Curzon G, Gibson EL, Oluyomi AO (1998) Appetite suppression by commonly used drugs depends on 5HT receptors but not on 5HT availability. Trends Pharmacol Sci 13:21–25
Fernstrom MH, Massoudi M, Kupfer DJ (1988) Fluvoxamine and weight loss. Biol Psychiatry 24:948–949
Garattini S, Bizzi A, Codegoni AM, Mennini T (1992) Progress report on the anorexia induced by drugs believed to mimic some of the effects of serotonin on the central nervous system. Am J Clin Nutr 55:160S–166S
Goldstein DJ, Rampey AH, Enas GG, Potvin JH, Fludzinski LA, Levine LR (1994) Fluoxetine: a randomized clinical trial in the treatment of obesity. Int J Obes Relat Metab Disord 18:129–135
Jackson JL (1976) Thiurea derivatives. US pat 3,985,898
Kennett GA (1998) 5-HT drugs and eating disorders. Drugs 1:456–470
Shor-Posner G, Grinker JA, Marinescu C, Brown O, Leibowitz SF (1986) Hypothalamic serotonin in the control of meal patterns and macronutrient selection. Brain Res Bull 17:663–671
Stahl SM (1998) Not so selective serotonin reuptake inhibitors. J Clin Psychiatry 59:343–344
Wadden TA, Bartlett SJ, Foster GD, Greenstein R, Wingate BJ, Stunkard AJ, Letizia KA (1995) Sertraline and relapse prevention training following treatment by very low calorie diet. Obes Res 3:549–557
Acknowledgements
Financial assistance from Council of Scientific and Industrial Research, New Delhi (SS and LS) and the University Grant Commission (NS) is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Additional information
C.D.R.I. communication No 7022
Rights and permissions
About this article
Cite this article
Bhandari, K., Srinivas, N., Sharma, L. et al. Substituted urea/thiourea derived from fluoxetine as potent appetite suppressants. Med Chem Res 17, 103–113 (2008). https://doi.org/10.1007/s00044-007-9041-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-007-9041-8